SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_33197683 Show fit | 3.60 |
ENST00000266085.6
|
TIMP metallopeptidase inhibitor 3 |
|
chr15_+_39873268 Show fit | 3.28 |
ENST00000397591.2
ENST00000260356.5 |
thrombospondin 1 |
|
chr12_+_4382917 Show fit | 2.86 |
ENST00000261254.3
|
cyclin D2 |
|
chr7_+_129932974 Show fit | 2.66 |
ENST00000445470.2
ENST00000222482.4 ENST00000492072.1 ENST00000473956.1 ENST00000493259.1 ENST00000486598.1 |
carboxypeptidase A4 |
|
chr13_-_107187462 Show fit | 2.15 |
ENST00000245323.4
|
ephrin-B2 |
|
chr6_+_47445467 Show fit | 2.10 |
ENST00000359314.5
|
CD2-associated protein |
|
chr8_-_49833978 Show fit | 1.82 |
ENST00000020945.1
|
snail family zinc finger 2 |
|
chr1_-_27816556 Show fit | 1.80 |
ENST00000536657.1
|
WAS protein family, member 2 |
|
chr1_+_112938803 Show fit | 1.76 |
ENST00000271277.6
|
CTTNBP2 N-terminal like |
|
chr10_+_5454505 Show fit | 1.76 |
ENST00000355029.4
|
neuroepithelial cell transforming 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.6 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 3.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.1 | 3.3 | GO:0002605 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 3.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 3.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 2.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 2.6 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 2.5 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.3 | 2.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 1.8 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 3.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 3.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 2.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 2.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 2.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 2.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 2.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 2.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 2.0 | GO:0016605 | PML body(GO:0016605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 4.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.8 | 3.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 2.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 2.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 2.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 2.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 2.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 2.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.9 | GO:0097016 | L27 domain binding(GO:0097016) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 5.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 4.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 3.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 3.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 2.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 2.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 3.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 3.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 2.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 2.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.7 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |